Article Text

0223: Epirubicin, Cisplatin and Capecitabine [Ecx] for Relapsed Epithelial Ovarian Cancer: Results of a Pilot Study

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.